A drug-induced sarcoidosis-like reaction (DISR) is a systemic granulomatous reaction that is
indistinguishable from sarcoidosis and occurs in a temporal relationship with initiation of an …

Sarcoidosis is a systemic disease of unknown etiology, characterized by the presence of
non-caseating granulomas in various organs, mainly the lungs, and the lymphatic system …

Novel targeted anti-cancer therapies have resulted in improvement in patient survival
compared to standard chemotherapy. Renal toxicities of targeted agents are increasingly …

Diagnosing pulmonary sarcoidosis raises challenges due to both the absence of a specific
diagnostic criterion and the varied presentations capable of mimicking many other …

The granulomatous dermatitides are a heterogenous group of conditions whose
etiopathogenesis is poorly understood. Granulomas are organized collections of histiocytes …

Survival for patients with multiple myeloma has significantly improved in the last decade in
large part due to the development of proteasome inhibitors and immunomodulatory drugs …

Highlights•Kinases are important enzymes, abnormally expressed in cancer.•Kinases are
potential targets of anticancer drugs.•Thymoquinone is a natural compound with anticancer …

Cancer patients experience kidney injury from multiple sources, including the tumor itself,
diagnostic procedures, hypovolemia, infection, and drug exposure, superimposed upon …

Background Granulomatous drug eruptions are rare entities, where granuloma formation
occurs as an attempt to contain an exogenous or endogenous inciting agent …

Therapy for advanced melanoma has deeply changed in the last decade with the
introduction of checkpoint and BRAF/MEK inhibitors. Granulomatous reactions have been …